# OnCo record nct07040436 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07040436/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07040436", "NCT07040436" ;
  schema:name "Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1"@en ;
  schema:description "A phase 1/2 trial of OPM-101 run by Oncodesign Precision Medicine, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07040436/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07040436> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/opm-101/> ;
  onco:companies <https://onco.cc/companies/oncodesign-precision-medicine/> .